New Delhi: Pharmaceutical pricing authority National Pharmaceutical Pricing Authority (NPPA) has capped prices of 18 formulations packs, including anti-diabetic Metformin HCl tablets, anti-bacterial Ceftriaxone Sodium injection packs and devices among others. The prices have also been fixed/revised for hormone releasing IUD, ondansetron HCl orally disintegrating strip, Metformin HCl tablets, Cefaclass injection pack among others.

The prices of the 18 formulation packs have been fixed/revised under the Drug Price Control Order (DPCO), 2013, the NPPA said in a statement. Drug firms such as Cipla Ltd, Alembic Pharmaceuticals Ltd and Unichem Laboratories Ltd will be impacted by the government’s move for prices fixation and revision. At present, the government caps prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1%.

In case of non scheduled formulations companies are allowed to hike prices of medicines by only up to 10% in a year. The government had notified DPCO, 2013, which covers 680 formulations, effective 15 May 2014, replacing the 1995 order that regulated only 74 bulk drugs.